Hongjing Zang

USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1

Jinghua Pan, Yiting Qiao, Congcong Chen et al. · Cell Death and Disease · 2021 · 71 citations · Full text

Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib

Lei Zhu, Zhen Chen, Hongjing Zang et al. · Cancer Research · 2021 · 64 citations · Full text

C-myc Modulation, Novel Therapy, Overcome Acquired Resistance +14

CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway

Qiuyuan Wen, Weiyuan Wang, Jiadi Luo et al. · Oncotarget · 2016 · 57 citations · Full text

Oncology, Mtor Inhibitors, Medicine +15

Suppression Of β-catenin Nuclear Translocation By CGP57380 Decelerates Poor Progression And Potentiates Radiation-Induced Apoptosis in Nasopharyngeal Carcinoma

Weiyuan Wang, Qiuyuan Wen, Jiadi Luo et al. · Theranostics · 2017 · 54 citations · Full text

Potentiates Radiation-induced Apoptosis, Apoptosis, Cell Death +19

ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor‐mutant non–small cell lung cancer cells to osimertinib

Yiting Li, Hongjing Zang, Guoqing Qian et al. · Cancer · 2019 · 50 citations · Full text